Xuebin B. Liao

State Key Laboratory Of Molecular Oncology
Beijing, 100084, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Rational Design and Identification of Highly Selective TLR8 Agonists as Potent HIV-1 Latency Reversal Agents.

Rational Design and Identification of Highly Selective TLR8 Agonists as Potent HIV-1 Latency Reversal Agents.

Journal: Journal of medicinal chemistry

Published: February 25, 2026

Profiling tumour-infiltrating immune cells in a large paediatric medulloblastoma cohort: a retrospective analysis.

Profiling tumour-infiltrating immune cells in a large paediatric medulloblastoma cohort: a retrospective analysis.

Journal: EBioMedicine

Published: July 25, 2025

Enhancing anti-tumour immunity through modulating dendritic cell activation by combination therapy with a novel TLR2 agonist and PD-L1 Blockade.

Enhancing anti-tumour immunity through modulating dendritic cell activation by combination therapy with a novel TLR2 agonist and PD-L1 Blockade.

Journal: Journal of experimental & clinical cancer research : CR

Published: May 09, 2025

Rational design, optimization, and biological evaluation of novel pyrrolo-pyridone derivatives as potent and orally active Cbl-b inhibitors.

Rational design, optimization, and biological evaluation of novel pyrrolo-pyridone derivatives as potent and orally active Cbl-b inhibitors.

Journal: European journal of medicinal chemistry

Published: January 12, 2025

Nickel-catalyzed domino annulation coupling to construct oxindole analogues: A mechanistic and synthetic investigation.

Nickel-catalyzed domino annulation coupling to construct oxindole analogues: A mechanistic and synthetic investigation.

Journal: iScience

Published: August 07, 2024

Current strategies for targeting HPK1 in cancer and the barriers to preclinical progress.

Current strategies for targeting HPK1 in cancer and the barriers to preclinical progress.

Journal: Expert opinion on therapeutic targets

Published: April 23, 2024

Protocol for Sonogashira coupling of alkynes and aryl halides via nickel catalysis.

Protocol for Sonogashira coupling of alkynes and aryl halides via nickel catalysis.

Journal: STAR protocols

Published: November 28, 2023

Mi-2β promotes immune evasion in melanoma by activating EZH2 methylation.

Mi-2β promotes immune evasion in melanoma by activating EZH2 methylation.

Journal: Nature communications

Published: October 18, 2023

Phase I study of peposertib and avelumab with or without palliative radiotherapy in patients with advanced solid tumors.

Phase I study of peposertib and avelumab with or without palliative radiotherapy in patients with advanced solid tumors.

Journal: ESMO open

Published: September 12, 2023

Single-cell transcriptomics identify TNFRSF1B as a novel T-cell exhaustion marker for ovarian cancer.

Single-cell transcriptomics identify TNFRSF1B as a novel T-cell exhaustion marker for ovarian cancer.

Journal: Clinical and translational medicine

Published: May 03, 2023

A novel CDK4/6 inhibitor combined with irradiation demonstrates potent anti-tumor efficacy in diffuse midline glioma.

A novel CDK4/6 inhibitor combined with irradiation demonstrates potent anti-tumor efficacy in diffuse midline glioma.

Journal: Journal of neuro-oncology

Published: March 08, 2023

Anti-tumor efficacy of anti-GD2 CAR NK-92 cells in diffuse intrinsic pontine gliomas.

Anti-tumor efficacy of anti-GD2 CAR NK-92 cells in diffuse intrinsic pontine gliomas.

Journal: Frontiers in immunology

Published: January 16, 2023

Showing 1-12 of 31

Last Updated: 09/26/2026